Efficacy and Safety of 30% Salicylic Acid and 10% Nicotinamide Combined Therapy in Melasma
Clinical trial NCT07062120 · COMPLETED
Trial details
- NCT number
- NCT07062120
- Sponsor
- Second Affiliated Hospital of Xi'an Jiaotong University
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-01
- Primary completion
- 2021-04-01
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.